CLVLY fundamentals
An in-depth look to Clinuvel Pharmaceuticals Ltd. operating, investing, and financing activities
CLVLY free cash flow for H1 24 is 13.75 M USD. For 2023, CLVLY free cash flow was 24.14 M USD and operating cash flow was 24.83 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM